NASDAQ:JAGX Jaguar Animal Health (JAGX) Stock Price, News & Analysis $0.37 -0.02 (-5.28%) As of 10:21 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsSEC Filings About Jaguar Animal Health Stock (NASDAQ:JAGX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Jaguar Animal Health alerts:Sign Up Key Stats Today's Range$0.37▼$0.3950-Day Range$0.39▼$34.4652-Week Range$0.36▼$981.75Volume91,597 shsAverage Volume689,195 shsMarket Capitalization$712.24 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Jaguar Health, Inc., formerly Jaguar Animal Health, develops prescription medicines for gastrointestinal disorders in humans and animals. The company’s research has focused on plant-derived compounds, including crofelemer, which is derived from the Croton lechleri tree. Jaguar’s animal-health product Canalevia-CA1 received FDA conditional approval for the treatment of chemotherapy-induced diarrhea in dogs. The company also develops and commercializes crofelemer-based medicines for human gastrointestinal conditions. Jaguar expanded beyond its original animal-health focus through its 2017 merger with Napo Pharmaceuticals, a company developing plant-based medicines for human health. Napo became a Jaguar subsidiary, and the combined company adopted the Jaguar Health name.AI Generated. May Contain Errors. Read More Jaguar Animal Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreJAGX MarketRank™: 0.27944111776 of 5 starsJaguar Animal Health scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingJaguar Animal Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageJaguar Animal Health has only been the subject of 1 research reports in the past 90 days.Read more about Jaguar Animal Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Jaguar Animal Health is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Jaguar Animal Health is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.33% of the float of Jaguar Animal Health has been sold short.Short Interest Ratio / Days to CoverJaguar Animal Health has a short interest ratio ("days to cover") of 0.37, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Jaguar Animal Health has recently increased by 42.84%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldJaguar Animal Health does not currently pay a dividend.Dividend GrowthJaguar Animal Health does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment1.61 News SentimentJaguar Animal Health has a news sentiment score of 1.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Jaguar Animal Health this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added Jaguar Animal Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Jaguar Animal Health insiders have not sold or bought any company stock.Percentage Held by Insiders0.12% of the stock of Jaguar Animal Health is held by insiders.Percentage Held by Institutions12.04% of the stock of Jaguar Animal Health is held by institutions.Read more about Jaguar Animal Health's insider trading history. Receive JAGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jaguar Animal Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JAGX Stock News HeadlinesJaguar Health to Hold Investor Webcast November 17 Regarding Q3 2026 Financials & Corporate UpdatesNovember 13, 2026 | usatoday.comNapo Pharmaceuticals provides recap of panel discussionNovember 2, 2026 | tipranks.comTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.November 17 at 1:00 AM | Base Camp Trading (Ad)CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference ...November 2, 2026 | theglobeandmail.comJaguar Health, Inc.(BOIN:) dropped from S&P TMI IndexNovember 1, 2026 | marketscreener.comMJaguar Health, Inc. Through Napo Pharmaceuticals Announces Crofelemer Shows Benefit for Intestinal Failure in Third Rare Congenital Enteropathy DisorderOctober 22, 2026 | marketscreener.comMJaguar Health’s Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy DisorderOctober 21, 2026 | usatoday.comReminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock DividendOctober 13, 2026 | theglobeandmail.comSee More Headlines JAGX Stock Analysis - Frequently Asked Questions How have JAGX shares performed this year? Jaguar Animal Health's stock was trading at $488.88 on January 1st, 2026. Since then, JAGX stock has decreased by 99.9% and is now trading at $0.3864. How were Jaguar Animal Health's earnings last quarter? Jaguar Animal Health, Inc. (NASDAQ:JAGX) posted its quarterly earnings data on Monday, November, 16th. The biotechnology company reported ($9.23) earnings per share for the quarter, topping the consensus estimate of ($444.29) by $435.06. The biotechnology company had revenue of $2.34 million for the quarter, compared to the consensus estimate of $4.85 million. When did Jaguar Animal Health's stock split? Shares of Jaguar Animal Health reverse split on Thursday, May 23rd 2024.The 1-60 reverse split was announced on Thursday, May 23rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, May 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Jaguar Animal Health IPO? Jaguar Animal Health (JAGX) raised $23 million in an initial public offering (IPO) on Wednesday, May 13th 2015. The company issued 2,860,000 shares at $7.00-$9.00 per share. Aegis Capital Corp served as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers. How do I buy shares of Jaguar Animal Health? Shares of JAGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Jaguar Animal Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Jaguar Animal Health investors own include NIO (NIO), Bionano Genomics (BNGO), Ocugen (OCGN), SNDL (SNDL), Tonix Pharmaceuticals (TNXP), Tesla (TSLA) and Plug Power (PLUG). Company Calendar Last Earnings11/16/2026Today11/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 12 days, JAGX's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:JAGX CIK1585608 Webwww.jaguar.health Phone(415) 371-8300FaxN/AEmployees47Year Founded2013Profitability EPS (Trailing Twelve Months)($3,731.34) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$53.43 million Net Margins-187.88% Pretax Margin-132.73% Return on EquityN/A Return on Assets-131.45% Debt Debt-to-Equity Ratio0.35 Current Ratio0.69 Quick Ratio0.40 Sales & Book Value Annual Sales$27.79 million Price / Sales0.03 Cash FlowN/A Price / Cash FlowN/A Book Value($1,591.00) per share Price / Book0.00Miscellaneous Outstanding Shares1,946,000Free Float1,944,000Market Cap$741.43 thousand OptionableNo Data Beta-0.09 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:JAGX) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredThe $40 trillion number nobody won on Tuesday will touchDemocrats took the House and Senate on election night, but the $40 trillion national debt and the $1 trillion ...Vault Metal | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredOne bank just ran the numbers on gold for the next 5 yearsDeutsche Bank's research team just modeled where gold could land by 2031 if central banks keep shifting reserv...Cedar Gold Group | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Animal Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jaguar Animal Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.